Contribute Try STAT+ Today

Hello, everyone, and how are you today? We are just fine, thank you, especially now that the Pharmalot campus has quieted down. The short person has long since left for the local schoolhouse and the official mascots have found comfy places to indulge their snoozing. As for us, we are busy foraging, as usual, for interesting items to pass along. On that note, here are some tidbits to help you get going. Hope your day is a successful one and you conquer the world. And of course, do keep in touch. We cherish your notes and calls …

AstraZeneca filed a lawsuit in a London court against a former executive, Luke Miels, for allegedly violating his employment agreement four months after he was hired by GlaxoSmithKline to run its pharmaceuticals business, Bloomberg News says. Last month, Glaxo said talks were under way to get Miels on board and hoped to reach a resolution soon. Miels was AstraZeneca’s executive vice president for Europe and is now on gardening leave (really?).

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • Selective bias. No one raised a “stink” when Williams and Williams Pharmaceuticals used a paid actor to promote their drug for inappropriate flatulence.

Comments are closed.